Current Understanding of Atherogenesis

American Journal of Medicine

Volumn 130, Issue 3, 2017, Pages 268-282

  Brown, Richard A ^a   Shantsila, Eduard ^a,b   Varma, Chetan ^b   Lip, Gregory Y H ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Atherogenesis; Coronary artery disease; Genetic factors; Inflammation

Indexed keywords

ADAPTIVE IMMUNITY; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CARDIAC PATIENT; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL MIGRATION; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; FIBRINOLYSIS; FOAM CELL; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CELL; THROMBOCYTE ACTIVATION; UPREGULATION; VASOCONSTRICTION; VASODILATATION; ARTERY; ATHEROSCLEROSIS; GENETICS; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ARTERIES; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 85009233106     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.10.022     Document Type: Review

References (108)

1. 1 Chiu, J.J., Chien, S., Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91 (2011), 327–387.
2. 2 Mann, D.L., Zipes, D.P., Libby, P., Bonow, R.O., Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed., 2015, Elsevier Saunders, Philadelphia.
3. 3 Davignon, J., Ganz, P., Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004), III27–III32.
4. 4 Furchgott, R.F., Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980), 373–376.
5. 5 Furchgott, R.F., Cherry, P.D., Zawadzki, J.V., Jothianandan, D., Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol 6:suppl 2 (1984), S336–S343.
6. 6 Van de Voorde, J., Leusen, I., Role of the endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur J Pharmacol 87 (1983), 113–120.
7. 7 Hutchinson, P.J., Palmer, R.M., Moncada, S., Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur J Pharmacol 141 (1987), 445–451.
8. 8 Palmer, R.M., Ashton, D.S., Moncada, S., Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333 (1988), 664–666.
9. 9 Saye, J.A., Singer, H.A., Peach, M.J., Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension 6 (1984), 216–221.
10. 10 Bonetti, P.O., Lerman, L.O., Lerman, A., Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23 (2003), 168–175.
11. 11 Zhang, J., Defelice, A.F., Hanig, J.P., Colatsky, T., Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury. Toxicol Pathol 38 (2010), 856–871.
12. 12 Blann, A.D., Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?. Blood Coagul Fibrinolysis 11 (2000), 623–630.
13. 13 Furchgott, R.F., Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. Vanhoutte, P.M., (eds.) Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, 1988, Raven Press, New York, 401–414.
14. 14 Sowers, J.R., Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346 (2002), 1999–2001.
15. 15 Deanfield, J.E., Halcox, J.P., Rabelink, T.J., Endothelial function and dysfunction: testing and clinical relevance. Circulation 115 (2007), 1285–1295.
16. 16 Hadi, H.A., Carr, C.S., Al Suwaidi, J., Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1 (2005), 183–198.
17. 17 Charakida, M., Donald, A.E., Terese, M., et al. Endothelial dysfunction in childhood infection. Circulation 111 (2005), 1660–1665.
18. 18 Pober, J.S., Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 133 (1988), 426–433.
19. 19 Chong, A.Y., Blann, A.D., Lip, G.Y.H., Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM 96 (2003), 253–267.
20. 20 Yaqoob, M., Patrick, A.W., McClelland, P., et al. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci (Lond) 85 (1993), 557–562.
21. 21 Makimattila, S., Virkamaki, A., Groop, P.H., et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94 (1996), 1276–1282.
22. 22 Johnstone, M.T., Creager, S.J., Scales, K.M., Cusco, J.A., Lee, B.K., Creager, M.A., Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88 (1993), 2510–2516.
23. 23 Clarkson, P., Celermajer, D.S., Donald, A.E., et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28 (1996), 573–579.
24. 24 Caballero, A.E., Arora, S., Saouaf, R., et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48 (1999), 1856–1862.
25. 25 Beer, S., Feihl, F., Ruiz, J., et al. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag 4 (2008), 1449–1458.
26. 26 Williams, S.B., Cusco, J.A., Roddy, M.A., Johnstone, M.T., Creager, M.A., Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27 (1996), 567–574.
27. 27 Panza, J.A., Quyyumi, A.A., Brush, J.E. Jr., Epstein, S.E., Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 (1990), 22–27.
28. 28 Spencer, C.G., Gurney, D., Blann, A.D., Beevers, D.G., Lip, G.Y., Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension 40 (2002), 61–66.
29. 29 Lip, G.Y., Blann, A.D., Zarifis, J., Beevers, M., Lip, P.L., Beevers, D.G., Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens 13 (1995), 1674–1678.
30. 30 Lip, G.Y., Edmunds, E., Hee, F.L., Blann, A.D., Beevers, D.G., A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 14 (2001), 823–828.
31. 31 Felmeden, D.C., Spencer, C.G., Belgore, F.M., Blann, A.D., Beevers, D.G., Lip, G.Y., Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 16 (2003), 11–20.
32. 32 Taddei, S., Virdis, A., Ghiadoni, L., et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38 (2001), 274–279.
33. 33 Shantsila, A., Dwivedi, G., Shantsila, E., Butt, M., Beevers, D.G., Lip, G.Y., Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension. Hypertension 57 (2011), 490–496.
34. 34 Schmidt-Lucke, C., Belgore, F., Reinhold, D., et al. Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. Int J Cardiol 100 (2005), 207–212.
35. 35 Harmer, J.A., Keech, A.C., Veillard, A.S., et al. Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy. Diabetes Res Clin Pract 106 (2014), 328–336.
36. 36 Newby, D.E., McLeod, A.L., Uren, N.G., et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: Direct link between endothelial dysfunction and atherothrombosis. Circulation 103 (2001), 1936–1941.
37. 37 Zeiher, A.M., Schachinger, V., Minners, J., Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92 (1995), 1094–1100.
38. 38 Johnson, H.M., Gossett, L.K., Piper, M.E., et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55 (2010), 1988–1995.
39. 39 Celermajer, D.S., Sorensen, K.E., Georgakopoulos, D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88 (1993), 2149–2155.
40. 40 Vlahos, A.P., Naka, K.K., Bechlioulis, A., et al. Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia. Pediatr Cardiol 35 (2014), 63–70.
41. 41 Gilligan, D.M., Guetta, V., Panza, J.A., Garcia, C.E., Quyyumi, A.A., Cannon, R.O. 3rd, Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 90 (1994), 35–41.
42. 42 Creager, M.A., Cooke, J.P., Mendelsohn, M.E., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86 (1990), 228–234.
43. 43 Sorensen, K.E., Celermajer, D.S., Georgakopoulos, D., Hatcher, G., Betteridge, D.J., Deanfield, J.E., Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 93 (1994), 50–55.
44. 44 Al Suwaidi, J., Higano, S.T., Holmes, D.R. Jr., Lennon, R., Lerman, A., Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37 (2001), 1523–1528.
45. 45 Francischetti, E.A., Tibirica, E., da Silva, E.G., Rodrigues, E., Celoria, B.M., de Abreu, V.G., Skin capillary density and microvascular reactivity in obese subjects with and without metabolic syndrome. Microvasc Res 81 (2011), 325–330.
46. 46 De Ciuceis, C., Porteri, E., Rizzoni, D., et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension 58 (2011), 29–36.
47. 47 Lee, K.W., Blann, A.D., Jolly, K., Lip, G.Y., Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study. Heart 92 (2006), 1732–1738.
48. 48 Lewis, T.V., Dart, A.M., Chin-Dusting, J.P., Kingwell, B.A., Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 19 (1999), 2782–2787.
49. 49 Harris, K.F., Matthews, K.A., Sutton-Tyrrell, K., Kuller, L.H., Associations between psychological traits and endothelial function in postmenopausal women. Psychosom Med 65 (2003), 402–409.
50. 50 Do, D.P., Dowd, J.B., Ranjit, N., House, J.S., Kaplan, G.A., Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med 72 (2010), 613–619.
51. 51 McCall, D.O., McGartland, C.P., McKinley, M.C., et al. Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 119 (2009), 2153–2160.
52. 52 Plotnick, G.D., Corretti, M.C., Vogel, R.A., Hesslink, R. Jr., Wise, J.A., Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. J Am Coll Cardiol 41 (2003), 1744–1749.
53. 53 Ali, A., Yazaki, Y., Njike, V.Y., Ma, Y., Katz, D.L., Effect of fruit and vegetable concentrates on endothelial function in metabolic syndrome: a randomized controlled trial. Nutr J, 10, 2011, 72.
54. 54 Djousse, L., Ellison, R.C., McLennan, C.E., et al. Acute effects of a high-fat meal with and without red wine on endothelial function in healthy subjects. Am J Cardiol 84 (1999), 660–664.
55. 55 Agewall, S., Wright, S., Doughty, R.N., Whalley, G.A., Duxbury, M., Sharpe, N., Does a glass of red wine improve endothelial function?. Eur Heart J 21 (2000), 74–78.
56. 56 Skaug, E.A., Aspenes, S.T., Oldervoll, L., et al. Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 Fitness Study. Eur J Prevent Cardiol 20 (2013), 531–540.
57. 57 Juonala, M., Kahonen, M., Laitinen, T., et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J 29 (2008), 1198–1206.
58. 58 Hashimoto, M., Akishita, M., Eto, M., et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92 (1995), 3431–3435.
59. 59 Celermajer, D.S., Sorensen, K.E., Spiegelhalter, D.J., Georgakopoulos, D., Robinson, J., Deanfield, J.E., Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24 (1994), 471–476.
60. 60 Schachinger, V., Britten, M.B., Elsner, M., Walter, D.H., Scharrer, I., Zeiher, A.M., A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation 100 (1999), 1502–1508.
61. 61 Clarkson, P., Celermajer, D.S., Powe, A.J., Donald, A.E., Henry, R.M., Deanfield, J.E., Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 96 (1997), 3378–3383.
62. 62 Donato, A.J., Eskurza, I., Silver, A.E., et al. Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB. Circ Res 100 (2007), 1659–1666.
63. 63 Houghton, J.L., Philbin, E.F., Strogatz, D.S., et al. The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. J Am Coll Cardiol 39 (2002), 1314–1322.
64. 64 Murphy, C., Kanaganayagam, G.S., Jiang, B., et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 27 (2007), 936–942.
65. 65 Loehr, L.R., Espeland, M.A., Sutton-Tyrrell, K., Burke, G.L., Crouse, J.R. 3rd, Herrington, D.M., Racial differences in endothelial function in postmenopausal women. Am Heart J 148 (2004), 606–611.
66. 66 McCrohon, J.A., Woo, K.S., Celermajer, D.S., A comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas 35 (2000), 31–37.
67. 67 Jaumdally, R.J., Varma, C., Blann, A.D., Macfadyen, R.J., Lip, G.Y., Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels. Ann Med 39 (2007), 628–633.
68. 68 Makin, A.J., Chung, N.A., Silverman, S.H., Lip, G.Y., Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity. Thromb Res 111 (2003), 221–226.
69. 69 Lip, G.Y.H., Blann, A.D., Jones, A.F., Lip, P.L., Beevers, D.G., Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 80 (1997), 1566–1571.
70. 70 Gunarathne, A., Patel, J.V., Kausar, S., Gammon, B., Hughes, E.A., Lip, G.Y.H., Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project. Stroke 40 (2009), 2298–2306.
71. 71 Yusuf, S., Hawken, S., Ounpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
72. 72 Yeboah, J., Folsom, A.R., Burke, G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120 (2009), 502–509.
73. 73 Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., Munzel, T., Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001), 2673–2678.
74. 74 Ishikawa, S., Shimano, M., Watarai, M., et al. Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus. Am J Cardiol 114 (2014), 384–388.
75. 75 Berenson, G.S., Srinivasan, S.R., Bao, W., Newman, W.P., Tracy, R.E., Wattigney, W.A., Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338 (1998), 1650–1656.
76. 76 Lim, H.S., Lip, G.Y., Blann, A.D., Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab 89 (2004), 5377–5381.
77. 77 Vasan, R.S., Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113 (2006), 2335–2362.
78. 78 Ridker, P.M., C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49 (2007), 2129–2138.
79. 79 Zhang, D., Sun, X., Liu, J., Xie, X., Cui, W., Zhu, Y., Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase. Arterioscler Thromb Vasc Biol 35 (2015), 71–78.
80. 80 Wang, T.J., New cardiovascular risk factors exist, but are they clinically useful?. Eur Heart J 29 (2008), 441–444.
81. 81 Long, E., The development of our knowledge of arteriosclerosis. Cowdry, E., (eds.) Arteriosclerosis: A Survey of the Problem, 1933, Macmillan, New York, 19–52.
82. 82 Snellen, H., A Disorder of the Breast. Collection of Original Texts on Ischaemic Heart Disease. 1976, Kooyker Scientific, Rotterdam.
83. 83 Warren, J., Remarks on angina pectoris. N Engl J Med 1 (1812), 1–11.
84. 84 Ruffer, M.A., On arterial lesions found in Egyptian mummies (1580 B.C.-525 A.D.). J Pathol Bacteriol 15 (1911), 453–462.
85. 85 Sandison, A.T., Degenerative vascular disease in the Egyptian mummy. Med Hist 6 (1962), 77–81.
86. 86 Virchow, R., Gesammalte Abhandlungen zur Wissenschaftlichen Medtzin. 1856, Medinger Sohn, Frankfurt.
87. 87 Blann, A.D., Lip, G.Y.H., Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res 101 (2001), 321–327.
88. 88 Duguid, J.B., Pathogenesis of atherosclerosis. Lancet 2 (1949), 925–927.
89. 89 Ross, R., Glomset, J.A., Atherosclerosis and the arterial smooth muscle cell. Science 180 (1973), 1332–1339.
90. 90 Ross, R., Glomset, J., Harker, L., Response to injury and atherogenesis. Am J Pathol 86 (1977), 675–684.
91. 91 Ross, R., Atherosclerosis–an inflammatory disease. N Engl J Med 340 (1999), 115–126.
92. 92 Libby, P., Ridker, P.M., Hansson, G.K., Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54 (2009), 2129–2138.
93. 93 Wang, J.C., Bennett, M., Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111 (2012), 245–259.
94. 94 Stary, H.C., Chandler, A.B., Dinsmore, R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15 (1995), 1512–1531.
95. 95 Simionescu, M., Sima, A., Morphology of atherosclerotic lesions. Wick, G., Grundtman, C., (eds.) Inflammation and Atherosclerosis, 2012, Springer, Vienna, 19–37.
96. 96 Stary, H.C., Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20 (2000), 1177–1178.
97. 97 Galkina, E., Ley, K., Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27 (2009), 165–197.
98. 98 Tedgui, A., Mallat, Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006), 515–581.
99. 99 Glagov, S., Weisenberg, E., Zarins, C.K., Stankunavicius, R., Kolettis, G.J., Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987), 1371–1375.
100. 100 Burke, A.P., Kolodgie, F.D., Farb, A., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103 (2001), 934–940.
101. 101 Jaipersad, A.S., Lip, G.Y., Silverman, S., Shantsila, E., The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63 (2014), 1–11.
102. 102 Jaipersad, A.S., Shantsila, A., Lip, G.Y., Shantsila, E., Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. Ann Med 46 (2014), 530–538.
103. 103 Theelen, T.L., Lappalainen, J.P., Sluimer, J.C., et al. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. Atherosclerosis 241 (2015), 297–304.
104. 104 Larsen, S.B., Grove, E.L., Wurtz, M., Neergaard-Petersen, S., Hvas, A.M., Kristensen, S.D., The influence of low-grade inflammation on platelets in patients with stable coronary artery disease. Thromb Haemost 114 (2015), 519–529.
105. 105 Roberts, R., Stewart, A.F.R., Genes and coronary artery disease: where are we?. J Am Coll Cardiol 60 (2012), 1715–1721.
106. 106 Ballantyne, C.M., Neutel, J., Cropp, A., et al. Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. Am J Cardiol 115 (2015), 1212–1221.
107. 107 Zhang, J., Zhao, F., Yu, X., Lu, X., Zheng, G., MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase. Int J Mol Med 35 (2015), 1708–1714.
108. 108 Robinson, H.C., Baker, A.H., How do microRNAs affect vascular smooth muscle cell biology?. Curr Opin Lipidol 23 (2012), 405–411.